FDA Black Box, VA Red Ink? A Successful Service-Connected Disability Claim for Chronic Neuropsychiatric Adverse Effects From Mefloquine.
Document Type
Journal Article
Publication Date
10-1-2016
Journal
Federal Practitioner
Volume
33
Issue
10
Inclusive Pages
20–24
APA Citation
Nevin, R., & Ritchie, E. (2016). FDA Black Box, VA Red Ink? A Successful Service-Connected Disability Claim for Chronic Neuropsychiatric Adverse Effects From Mefloquine.. Federal Practitioner, 33 (10). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_psych_facpubs/531
COinS